Aspirin in the prevention of preeclampsia: the conundrum of how, who and when

被引：0
作者：
Renuka Shanmugalingam
Annemarie Hennessy
Angela Makris
机构：
[1] South Western Sydney Local Health District,Department of Renal Medicine
[2] Western Sydney University,School of Medicine
来源：
Journal of Human Hypertension | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Aspirin is widely used in preventing early onset preeclampsia in women who are identified as being high risk. Although the benefit of aspirin is increasingly evident and acknowledged, there remains many unanswered questions with regards to its optimal application in pregnancy. The issues mainly centre around the relatively modest risk reduction that is observed with the use of aspirin prophylactically. We aim to explore the reasons behind the conservative rate of benefit and aim to explore factors that are likely to influence the outcomes with the use of aspirin.
引用
收藏
页码：1 / 9
页数：8
相关论文
共 384 条
  • [1] Duley L(2009)The global impact of pre-eclampsia and eclampsia Semin Perinatol 33 130-7
  • [2] Jeyabalan A(2013)Epidemiology of preeclampsia: impact of obesity Nutr Rev 71 S18-25
  • [3] Thornton C(2013)The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008 Am J Obstet Gynecol 208 476 e1-5
  • [4] Dahlen H(2003)Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 649-58
  • [5] Korda A(2006)Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 992-1005
  • [6] Hennessy A(2005)Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia Pediatr Res 57 1R-7R
  • [7] Maynard SE(2016)Placental growth factor reduces blood pressure in a uteroplacental ischemia model of preeclampsia in nonhuman primates Hypertension 67 1263-72
  • [8] Min JY(2017)Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction Hypertension 69 457-68
  • [9] Merchan J(2016)Removal of soluble Fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia J Am Soc Nephrol 27 903-13
  • [10] Lim KH(2014)A1M/alpha1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia PLoS ONE 9 e86353-22
12345678910